Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kasabach-merritt syndrome.

Sheilagh Maguiness1, Lyn Guenther

  • 1University of Western Ontario, London, Ontario, Canada.

Journal of Cutaneous Medicine and Surgery
|April 16, 2002
PubMed
Summary

Kasabach-Merritt syndrome (KMS) is a rare coagulopathy linked to vascular tumors. This review summarizes current treatment strategies for this challenging condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Social Unrest and Its Implications on the Pediatric Dermatological Patient: Lessons From a Single Center Academic Dermatology Department.

Pediatric dermatology·2026
Same author

Effect of Delgocitinib Cream on Health-Related Quality of Life in Patients With Moderate to Severe Chronic Hand Eczema.

Contact dermatitis·2026
Same author

Results from the 32-week, phase 3 DISCREET study of apremilast in patients with moderate to severe genital psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Scrolling for Solutions: Social Media Use Among Caregivers in Pediatric Dermatology.

Pediatric dermatology·2025
Same author

Vaccination in adults at-increased risk of herpes zoster in Canada: insights from a multidisciplinary panel consensus.

Expert review of vaccines·2025
Same author

Commentary on Nurturing Youth: Ethical Considerations in Pediatric Skincare Marketing.

Pediatric dermatology·2025

Area of Science:

  • Vascular Medicine
  • Pediatric Hematology
  • Oncology

Background:

  • Kasabach-Merritt syndrome (KMS) is a consumptive coagulopathy associated with large vascular lesions like kaposiform hemangioendothelioma (KHE) and tufted angioma (TA).
  • KMS presents a high mortality rate and lacks established treatment guidelines, often requiring a multimodal therapeutic approach.
  • These aggressive vascular tumors are locally invasive, posing significant treatment challenges.

Purpose of the Study:

  • To provide a comprehensive review of Kasabach-Merritt syndrome (KMS).
  • To summarize current and emerging treatment options for KMS.
  • To discuss the clinical presentation, laboratory findings, vascular pathology, and pathophysiology of KMS.

Main Methods:

  • Literature review of case reports and existing studies on Kasabach-Merritt syndrome.
  • Analysis of treatment modalities including supportive care, local therapies, pharmacotherapy, and surgical interventions.
  • Synthesis of information on clinical, laboratory, and pathological aspects of KMS.

Main Results:

  • Kasabach-Merritt syndrome (KMS) is characterized by a consumptive coagulopathy and aggressive vascular tumors (KHE, TA).
  • Treatment is often multimodal, involving supportive care, local therapies, and systemic drug or surgical management.
  • A comprehensive understanding of KMS pathophysiology is crucial for effective management.

Conclusions:

  • Kasabach-Merritt syndrome (KMS) requires a multidisciplinary approach due to its complexity and high mortality.
  • Further research is needed to establish evidence-based treatment guidelines for KMS.
  • Early diagnosis and tailored therapeutic strategies are essential for improving patient outcomes.

Related Experiment Videos